The researchers engineered a compound that kills leukemia cells with potency comparable to FDA-approved therapies by ...

Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer immunotherapy drugs. The findings may help unlock the full potential of TcEs and ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

The toxic fungus Aspergillus flavus— known as the “Pharaoh’s Curse” due to its role in the deaths of archaeologists who ...

Confocal z-stack image a T cell on the 0.5-4-0.5 surface, showing the cell membrane in red, nucleus in blue and the pillar surface in gray. Image is 18x18 μm in size and 2.5 μm in height. Credit ...

Cell Potency Screening Might Be Needed. In the feasibility trial, mononuclear cells from bone marrow aspirate that has high numbers of specific cell types, such as CD34+ positive cells, produced ...

During the oral presentation “Cell Mimics As High Precision Controls for CGT Analytics and Potency Assays” Robyn Hall, Ph.D., Cell Therapy Specialist at Slingshot Biosciences, will highlight ...

In addition to monitoring the cells’ potency, the Cedars-Sinai team plans to investigate whether DNA can effectively be introduced into the cells in the space station’s zero-G environment.

When the scientists inserted the CARD11-PIK3R3 mutation into healthy T cells and tested them against a line of leukemia cells, potency was dramatically increased.

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...

Artificial nanostructured surfaces mimicking natural cell environments enhance CAR T-cell activation, longevity, and potency by promoting the generation of central memory T cells.

Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of biomarker cell mimics specifically designed for ...